These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26521482)

  • 1. [The Role of Iron and Alpha-synuclein Interacting in Parkinson's Disease].
    Wang J; Song N; Xu HM; Jiang H; Xie JX
    Sheng Li Ke Xue Jin Zhan; 2015 Jun; 46(3):180-4. PubMed ID: 26521482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between iron and α-synuclein pathology in Parkinson's disease.
    Chen B; Wen X; Jiang H; Wang J; Song N; Xie J
    Free Radic Biol Med; 2019 Sep; 141():253-260. PubMed ID: 31233777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's disease.
    Sian-Hulsmann J; Riederer P
    J Neural Transm (Vienna); 2020 May; 127(5):749-754. PubMed ID: 32318880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron promotes the clearance of α-synuclein: An Editorial for 'H63D variant of the homeostatic iron regulator (HFE) gene alters α-synuclein expression, aggregation, and toxicity" on page 177.
    Tuo QZ; Lei P
    J Neurochem; 2020 Sep; 155(2):117-119. PubMed ID: 32754933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL.
    McDowall JS; Ntai I; Honeychurch KC; Hart JP; Colin P; Schneider BL; Brown DR
    Mol Cell Neurosci; 2017 Dec; 85():1-11. PubMed ID: 28811225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition.
    Wu KC; Liou HH; Kao YH; Lee CY; Lin CJ
    Neurobiol Dis; 2017 Aug; 104():61-72. PubMed ID: 28476637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron and Parkinson's disease.
    Wolozin B; Golts N
    Neuroscientist; 2002 Feb; 8(1):22-32. PubMed ID: 11843096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational modification of α-synuclein in Parkinson's disease.
    Barrett PJ; Timothy Greenamyre J
    Brain Res; 2015 Dec; 1628(Pt B):247-253. PubMed ID: 26080075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
    Sharma N; Nehru B
    Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease.
    Bharathi P; Nagabhushan P; Rao KS
    Comput Biol Med; 2008 Oct; 38(10):1084-93. PubMed ID: 18823621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity.
    He Q; Song N; Jia F; Xu H; Yu X; Xie J; Jiang H
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1019-30. PubMed ID: 23454680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein as a ferrireductase.
    Brown DR
    Biochem Soc Trans; 2013 Dec; 41(6):1513-7. PubMed ID: 24256246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B; Zhang Y; Yuan Y; Chen N
    Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.